NIH Awards $640K Grant to Rutgers Researcher for Rapid Ebola Dx | GenomeWeb

NEW YORK (GenomeWeb) – The National Institutes of Health has awarded Rutgers New Jersey Medical School researcher David Alland a $640,000 grant to develop a rapid detection test for the Ebola virus.

The amplicon-nested PCR-based assay is designed to be performed on Cepheid's GeneXpert platform using the firm's assay cartridges.

The Ebola test would analyze small amounts of patients' blood or samples taken from cheek swabs. Alland said in a statement that he hopes to develop the assay within the next 15 months.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.